Retraction: MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma (PLoS ONE (2015) 10:4 (e0122851) DOI: 10.1371/journal.pone.0122851);MiR-506 Suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zhang, Zhanchi ^a   Ma, Jun ^a   Luan, Guang ^a   Kang, Lin ^a   Su, Yuhong ^a   He, Yanan ^a   Luan, Feng ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD BOX Q1; MICRORNA; MICRORNA 506; TUMOR PROTEIN; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXQ1 PROTEIN, HUMAN; LUCIFERASE; MIRN506 MICRORNA, HUMAN;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL LINE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; NASOPHARYNX CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR INVASION; UPREGULATION; CELL MOTION; DIFFUSION CHAMBER; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DIFFUSION CHAMBERS, CULTURE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84929493692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0266301     Document Type: Erratum

References (48)

1. Lu J, Zhao FP, Peng Z, Zhang MW, Lin SX, Liang BJ, et al. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. Oncotarget. 2014; 5(22):11319-32. PMID: 25237831.
2. Chen LX, Zhu LY, Jacob TJ, Wang LW. Roles of volume-activated Cl- currents and regulatory volume decrease in the cell cycle and proliferation in nasopharyngeal carcinoma cells. Cell proliferation. 2007; 40(2):253-67. PMID: 17472731.
3. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, et al. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis. 2013; 34(2):415-25. doi:10.1093/carcin/bgs329 PMID: 23097559.
4. Ye Y, Zhou Y, Zhang L, Chen Y, Lyu X, Cai L, et al. EBV-miR-BART1 is involved in regulating metabolism- associated genes in nasopharyngeal carcinoma. Biochemical and biophysical research communications. 2013; 436(1):19-24. doi:10.1016/j.bbrc.2013.05.008 PMID: 23685147.
5. Li L, Wu J, Sima X, Bai P, Deng W, Deng X, et al. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour biology: The journal of the International Society for Oncodevelopmental Biology and Medicine. 2013; 34(3):1919-23. doi:10.1007/s13277-013-0736-9 PMID: 23504554.
6. Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, et al. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell death & disease. 2013; 4:e872.
7. Zhang T, Sun Q, Liu T, Chen J, Du S, Ren C, et al. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14). Tumour biology: The journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35(12):12593-9. doi:10.1007/s13277-014-2581-x PMID: 25201065.
8. Huang GL, Chen ML, Li YZ, Lu Y, Pu XX, He YX, et al. Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population. Journal of human genetics. 2014; 59(3):141-4. doi:10.1038/jhg.2013.135 PMID: 24430575.
9. Huang GL, Lu Y, Pu XX, He YX, Chen ML, Li YZ, et al. Association study between miR-149 gene polymorphism and nasopharyngeal carcinoma. Biomedical reports. 2013; 1(4):599-603. PMID: 24648993.
10. Luo X, Dong Z, Chen Y, Yang L, Lai D. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway. Cell proliferation. 2013; 46(4):436-46. doi:10.1111/cpr.12038 PMID: 23869765.
11. Ohdaira H, Sekiguchi M, Miyata K, Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell proliferation. 2012; 45(1):32-8. doi:10.1111/j.1365-2184.2011.00798.x PMID: 22151897.
12. Li Z, Yu X, Shen J, Wu WK, Chan MT. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell proliferation. 2015; 48(1):1-6. doi:10.1111/cpr.12160 PMID: 25530497.
13. Fu LL, Zhao X, Xu HL, Wen X, Wang SY, Liu B, et al. Identification of microRNA-regulated autophagic pathways in plant lectin-induced cancer cell death. Cell proliferation. 2012; 45(5):477-85. doi:10.1111/j.1365-2184.2012.00840.x PMID: 22882626.
14. Fei B, Wu H. MiR-378 Inhibits Progression of Human Gastric Cancer MGC-803 Cells by Targeting MAPK1 In Vitro. Oncology research. 2013; 20(12):557-64.
15. Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y, et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2015; 18(1):43-54. doi:10.1007/s10120-014-0340-8 PMID: 24481854.
16. Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X, et al. MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PloS one. 2013; 8(12):e83080. doi:10.1371/journal.pone.0083080 PMID: 24376640.
17. Li J, You T, Jing J. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Cell proliferation. 2014; 47(2):152-60. doi:10.1111/cpr.12093 PMID: 24517182.
18. Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D, Kiefel H, et al. Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget. 2014; 5(2):462-72. PMID: 24497324.
19. Xiao X, Tang C, Xiao S, Fu C, Yu P. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells. Oncology research. 2013; 20(11):537-44. doi:10.3727/096504013X13775486749335 PMID: 24063284.
20. Ohno M, Otsuka M, Kishikawa T, Shibata C, Yoshikawa T, Takata A, et al. Specific delivery of micro- RNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA. Oncotarget. 2014; 5(14):5581-90. PMID: 25026299.
21. He X, Li J, Guo W, Liu W, Yu J, Song W, et al. Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma. Oncotarget. 2014.
22. Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014.
23. Dylla L, Jedlicka P. Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma. PloS one. 2013; 8(4):e63032. doi:10.1371/journal.pone.0063032 PMID: 23638178.
24. Xu Y, Jin J, Liu Y, Huang Z, Deng Y, You T, et al. Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. PloS one. 2014; 9(7):e99516. doi: 10.1371/journal.pone.0099516 PMID: 25055044.
25. Fei B, Wu H. MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncology research. 2012; 20(12):557-64. doi:10.3727/096504013X13775486749254 PMID: 24139413.
26. Han G, Wang Y, Bi W. C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway. Oncology research. 2012; 20(4):149-56. PMID: 23461061.
27. Wang K, Jia Z, Zou J, Zhang A, Wang G, Hao J, et al. Analysis of hsa-miR-30a-5p expression in human gliomas. Pathology oncology research: POR. 2013; 19(3):405-11. doi:10.1007/s12253-012-9593-x PMID: 23606081.
28. Wu W, He X, Kong J, Ye B. Mir-373 affects human lung cancer cells' growth and its E-cadherin expression. Oncology research. 2012; 20(4):163-70. PMID: 23461063.
29. Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. The Journal of pathology. 2014; 233(3):308-18. doi:10.1002/path.4348 PMID: 24604117.
30. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. The Journal of pathology. 2015; 235(1):25-36. doi:10.1002/path.4443 PMID: 25230372.
31. Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM, et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2014.
32. Wu J, Peng X, Zhou A, Qiao M, Wu H, Xiao H, et al. MiR-506 inhibits PRRSV replication in MARC-145 cells via CD151. Molecular and cellular biochemistry. 2014; 394(1-2):275-81. doi:10.1007/s11010-014-2073-8 PMID: 24961950.
33. Wang Y, Cui M, Sun BD, Liu FB, Zhang XD, Ye LH. MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR. Acta pharmacologica Sinica. 2014; 35(9):1207-14. doi:10.1038/aps.2014.59 PMID: 25087998.
34. Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K, et al. Selective killing of lung cancer cells by miRNA- 506 molecule through inhibiting NF-kappaB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene. 2014.
35. Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P, et al. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 2012; 31(12):1558-70. doi:10.1038/onc.2011.345 PMID: 21860416.
36. Christensen J, Bentz S, Sengstag T, Shastri VP, Anderle P. FOXQ1, a novel target of the Wnt pathway and a new marker for activation of Wnt signaling in solid tumors. PloS one. 2013; 8(3):e60051. doi:10.1371/journal.pone.0060051 PMID: 23555880.
37. Katoh M. Human FOX gene family (Review). International journal of oncology. 2004; 25(5):1495-500. PMID: 15492844.
38. Sun HT, Cheng SX, Tu Y, Li XH, Zhang S. FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression. PloS one. 2013; 8(1):e55693. doi:10.1371/journal.pone.0055693 PMID: 23383267.
39. Liang SH, Yan XZ, Wang BL, Jin HF, Yao LP, Li YN, et al. Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer. Tumour biology: The journal of the International Society for Oncodevelopmental Biology and Medicine. 2013; 34(5):2605-9. doi:10.1007/s13277-013-0808-xPMID:23609035.
40. Feng J, Xu L, Ni S, Gu J, Zhu H, Wang H, et al. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity. Oncotarget. 2014; 5(20):9689-702. PMID: 25356753.
41. Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, et al. Pancreatic cancer stemlike cells display aggressive behavior mediated via activation of FoxQ1. The Journal of biological chemistry. 2014; 289(21):14520-33. doi:10.1074/jbc.M113.532887 PMID: 24719318.
42. Wang W, He S, Ji J, Huang J, Zhang S, Zhang Y. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma. Pathology, research and practice. 2013; 209 (6):353-8. doi:10.1016/j.prp.2013.03.005 PMID: 23623360.
43. Sehrawat A, Kim SH, Vogt A, Singh SV. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells. Carcinogenesis. 2013; 34 (4):864-73. doi:10.1093/carcin/bgs397 PMID: 23276794.
44. Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi SC, Yu Q. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer research. 2011; 71(8):3076-86. doi:10.1158/0008-5472.CAN-10-2787 PMID: 21346143.
45. Peng XH, Huang HR, Lu J, Liu X, Zhao FP, Zhang B, et al. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Molecular cancer. 2014; 13:186. doi:10.1186/1476-4598-13-186 PMID: 25098939.
46. Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, et al. microRNA-141 is involved in a nasopharyngeal carcinoma- related genes network. Carcinogenesis. 2010; 31(4):559-66. doi:10.1093/carcin/bgp335 PMID: 20053927.
47. Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G, et al. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways. PloS one. 2012; 7 (12):e53176. doi:10.1371/journal.pone.0053176 PMID: 23300886.
48. Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G, et al. The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2013; 31(6):847-57. doi:10.1002/jor.22308 PMID: 23335226.